Cary Street Partners Investment Advisory LLC Has $242,000 Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

Cary Street Partners Investment Advisory LLC lessened its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXXFree Report) by 13.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 436 shares of the company’s stock after selling 67 shares during the quarter. Cary Street Partners Investment Advisory LLC’s holdings in IDEXX Laboratories were worth $242,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in IDXX. OFI Invest Asset Management bought a new position in shares of IDEXX Laboratories during the 3rd quarter valued at about $25,000. Valley National Advisers Inc. increased its position in shares of IDEXX Laboratories by 84.6% during the fourth quarter. Valley National Advisers Inc. now owns 48 shares of the company’s stock worth $26,000 after acquiring an additional 22 shares in the last quarter. Geo Capital Gestora de Recursos Ltd acquired a new stake in shares of IDEXX Laboratories during the third quarter worth $28,000. Covestor Ltd lifted its position in IDEXX Laboratories by 71.8% in the 3rd quarter. Covestor Ltd now owns 67 shares of the company’s stock valued at $29,000 after acquiring an additional 28 shares in the last quarter. Finally, Venturi Wealth Management LLC increased its holdings in IDEXX Laboratories by 226.3% during the 4th quarter. Venturi Wealth Management LLC now owns 62 shares of the company’s stock worth $34,000 after purchasing an additional 43 shares in the last quarter. 87.84% of the stock is currently owned by institutional investors.

IDEXX Laboratories Stock Up 5.3 %

IDEXX Laboratories stock opened at $548.53 on Thursday. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.57 and a quick ratio of 1.16. The company’s 50-day moving average is $512.97 and its 200-day moving average is $517.59. The firm has a market capitalization of $45.30 billion, a PE ratio of 53.10, a P/E/G ratio of 3.96 and a beta of 1.27. IDEXX Laboratories, Inc. has a fifty-two week low of $372.50 and a fifty-two week high of $583.39.

Analysts Set New Price Targets

IDXX has been the topic of a number of research reports. Barclays cut their price target on IDEXX Laboratories from $655.00 to $570.00 and set an “overweight” rating on the stock in a report on Thursday, May 2nd. JPMorgan Chase & Co. lifted their price objective on shares of IDEXX Laboratories from $600.00 to $630.00 and gave the company an “overweight” rating in a report on Tuesday, February 6th. Piper Sandler cut shares of IDEXX Laboratories from an “overweight” rating to a “neutral” rating and set a $525.00 target price for the company. in a report on Tuesday, January 30th. William Blair reiterated an “outperform” rating on shares of IDEXX Laboratories in a research note on Tuesday, April 9th. Finally, StockNews.com upgraded shares of IDEXX Laboratories from a “hold” rating to a “buy” rating in a research note on Tuesday. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $580.38.

Get Our Latest Stock Report on IDXX

IDEXX Laboratories Company Profile

(Free Report)

IDEXX Laboratories, Inc develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.

Read More

Want to see what other hedge funds are holding IDXX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IDEXX Laboratories, Inc. (NASDAQ:IDXXFree Report).

Institutional Ownership by Quarter for IDEXX Laboratories (NASDAQ:IDXX)

Receive News & Ratings for IDEXX Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEXX Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.